Rituximab treatment in patients with primary Sjögren's syndrome: An open‐label phase II study

The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

1992 • 33,264 citations

The MOS 36-ltem Short-Form Health Survey (SF-36)

1992 • 26,794 citations

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

2002 • 5,269 citations

Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

2002 • 5,065 citations

Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

1999 • 3,484 citations

The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue

1995 • 3,198 citations

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1998 • 2,777 citations

Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis

2004 • 2,504 citations

IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

1997 • 1,652 citations

Diagnostic Tests in the Sicca Syndrome

1969 • 1,080 citations

B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose‐escalation trial of rituximab

2004 • 768 citations

Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal Antibody (Rituximab, IDEC-C2B8)

1999 • 653 citations

An open study of B lymphocyte depletion in systemic lupus erythematosus

2002 • 573 citations

Malignant lymphoma in primary Sj�gren's syndrome: A multicenter, retrospective, clinical study by the European concerted action on Sj�gren's syndrome

1999 • 484 citations

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

2004 • 392 citations

Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type

2003 • 388 citations

Rituximab therapy and autoimmune disorders: Prospects for anti–B cell therapy

2003 • 363 citations

Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion

2002 • 345 citations

Rheumatoid factor revisited

2004 • 233 citations

Health-related quality of life in primary Sjögren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36

2000 • 186 citations

Fatigue in primary Sjogren's syndrome

1998 • 162 citations

Infliximab in patients with primary Sj�gren's syndrome: A pilot study

2001 • 153 citations

IgG4 as a blocking antibody

1983 • 110 citations

Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells

2000 • 104 citations

Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren's syndrome and associated MALT lymphoma

2004 • 102 citations

Prednisone and piroxicam for treatment of primary Sjögren's syndrome.

1993 • 95 citations

Sialometry and sialochemistry: a non-invasive approach for diagnosing Sjogren's syndrome

2002 • 95 citations

Current concepts on diagnosis, autoantibodies and therapy in Sj gren's syndrome

2000 • 94 citations

Serum sickness secondary to treatment with the murine-human chimeric antibody IDEC-C2B8 (rituximab)

2001 • 93 citations

Sialochemistry in Sjögren's syndrome

1976 • 85 citations

Primary Sjögren's syndrome: salivary gland function and clinical oral findings

1999 • 78 citations

Improvement in Sjögren's syndrome following therapy with rituximab for marginal zone lymphoma

2003 • 71 citations

Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjogren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas

2004 • 64 citations

Treatment of oral dryness related complaints (xerostomia) in Sjogren's syndrome

1999 • 59 citations

Rituximab in autoimmune diseases

2004 • 42 citations

Primary Sjögren's syndrome—clinical and laboratory markers of disease activity

1992 • 39 citations

F-18 FDG positron emission tomography demonstrates resolution of non-Hodgkin's lymphoma of the parotid gland in a patient with Sjogren's syndrome: before and after anti-CD20 antibody rituximab therapy.

2002 • 38 citations

Outcome measures for Sjögren's syndrome, April 10-11, 2003, Bethesda, Maryland, USA.

2005 • 38 citations

Oral and ocular manifestations in Sjögren's syndrome.

2002 • 27 citations

Clinical reviews in allergy

1987 • 22 citations

Applicability of Saliva as a Diagnostic Fluid in Sjögren's Syndrome

1993 • 21 citations